SLBT (SL Science Holding) EV-to-EBITDA: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SLBT SL Science Holding Ltd SLBT
12 GF Score
Price $1.73
! 5 Warning Signs
View Full Analysis

What is SL Science Holding EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SL Science Holding's enterprise value is $952.25 Mil. SL Science Holding does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate SL Science Holding's EV-to-EBITDA at this moment.

The historical rank and industry rank for SL Science Holding's EV-to-EBITDA or its related term are showing as below:

SLBT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -66875.44   Med: -431.07   Max: -275.31
Current: -59515.5

During the past 1 years, the highest EV-to-EBITDA of SL Science Holding was -275.31. The lowest was -66875.44. And the median was -431.07.

SLBT's EV-to-EBITDA is ranked worse than
100% of 431 companies
in the Biotechnology industry
Industry Median: 12.97 vs SLBT: -59515.50

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-09-20), SL Science Holding's stock price is $1.73. SL Science Holding does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate SL Science Holding's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

SL Science Holding  (NAS:SLBT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

SL Science Holding's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.73/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

SL Science Holding EV-to-EBITDA Related Terms

SL Science Holding EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for SL Science Holding's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SL Science Holding EV-to-EBITDA Chart

SL Science Holding Annual Data
Trend Dec25
EV-to-EBITDA
-

SL Science Holding Quarterly Data
Dec25
EV-to-EBITDA -

SLBT vs MAZE, INVA, NVAX: EV-to-EBITDA Comparison

For the Biotechnology subindustry, SL Science Holding's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SL Science Holding EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SL Science Holding's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SL Science Holding's EV-to-EBITDA falls into.


SLBT
12GF Score
SL Science Holding Ltd SLBT
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SL Science Holding EV-to-EBITDA Calculation

SL Science Holding's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=952.248/
=

SL Science Holding Business Description

Address No. 479 Chongyang Road, 11th Floor, Nangang District, Taipei, TWN, 115010
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
12GF Score

Get the complete analysis for SLBT

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.73
Price